주사 펜 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Injection Pen Market size is expected to reach USD 106.36 Billion in 2034 from USD 52.20 Billion (2025) growing at a CAGR of 8.23% during 2026-2034.

The Global Injection Pen Market is witnessing steady growth driven by the increasing prevalence of chronic conditions such as diabetes, growth hormone deficiencies, and autoimmune disorders. Injection pens offer improved dosing accuracy, convenience, and patient compliance compared to traditional syringes. Their user-friendly design has made them a preferred option for self-administration in home care settings.

Market growth is supported by the rising geriatric population, advancements in drug delivery technologies, and increasing awareness of self-care management. Pharmaceutical companies are developing smart injection pens with digital tracking features to enhance adherence and data monitoring. Additionally, expanding healthcare access in emerging economies is contributing to market expansion.

Future prospects remain strong as innovation focuses on connected devices, reusable pens, and eco-friendly designs. Integration with mobile health applications and digital health platforms is expected to further enhance patient engagement. As healthcare shifts toward personalized and home-based care models, injection pens will continue to play a significant role in improving treatment outcomes and patient convenience.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Therapy

• Growth Hormone
• Osteoporosis
• Fertility
• Others
• Diabetes

By End Users

• Home-care Settings
• Hospital and Clinics

By Type

• Disposable Injection Pen
• Reusable Injection Pen

COMPANIES PROFILED

• List of Companies Profiled in the Report ： Sanofi, AstraZeneca, Pfizer Inc, Biocon, Novo Nordisk AS, Becton, Dickinson and Company, Ypsomed AG, Novartis AG, Merck Group, Eli Lilly and Company
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INJECTION PEN MARKET: BY THERAPY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Therapy
• 4.2. Growth Hormone Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Osteoporosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Fertility Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INJECTION PEN MARKET: BY END USERS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Users
• 5.2. Home-care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hospital and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INJECTION PEN MARKET: BY TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Type
• 6.2. Disposable Injection Pen Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Reusable Injection Pen Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INJECTION PEN MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Therapy
  • 7.2.2 By End Users
  • 7.2.3 By Type
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Therapy
  • 7.3.2 By End Users
  • 7.3.3 By Type
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Therapy
  • 7.4.2 By End Users
  • 7.4.3 By Type
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Therapy
  • 7.5.2 By End Users
  • 7.5.3 By Type
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Therapy
  • 7.6.2 By End Users
  • 7.6.3 By Type
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL INJECTION PEN INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Sanofi
  • 9.2.2 AstraZeneca
  • 9.2.3 Pfizer Inc
  • 9.2.4 Biocon
  • 9.2.5 Novo Nordisk A/S
  • 9.2.6 Becton
  • 9.2.7 Dickinson And Company
  • 9.2.8 Ypsomed AG
  • 9.2.9 Novartis AG
  • 9.2.10 Merck Group
  • 9.2.11 Eli Lilly And Company